8月4日，昭衍新药（06127.HK）盘中上涨5.46%，报23.92港元，成交额3981.88万港元。
消息面上，生命科学工具和服务板块全线大幅走强，药明康德涨13.2%、康龙化成涨8.63%、金斯瑞生物科技涨7.61%、药明合联涨6.33%、药明生物涨5.26%，板块个股普遍录得显著涨幅。此前CRO行业多家头部企业一季度新签订单实现大幅增长，行业订单全面回暖趋势延续，叠加公司此前确认非人灵长类实验动物供需呈紧张状态、价格较前期有所增长，基本面支撑下板块联动效应显著。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.